|
10
CGT Manufacturing 2023
Oxford Global’s Cell & Gene Therapy Manufacturing and Supply Chain Congress aim to address key bottlenecks within the supply and manufacture of cell and gene therapies globally. Taking place on the 10-11th May 2023, Ireland Dublin, the event aims to bring together key industry leaders in Ireland the hub of cell and gene therapy manufacturing investment.
Hear case studies on the cell and gene therapy landscape in Ireland, and the development of new manufacturing facilities. Presentations will showcase both viral and non-viral vector engineering and the acceleration of analytical tools and techniques to speed up process development, as well as streamlining CGT manufacture.
Connect with over 150 attendees and benefit from 20+ presentations and interactive sessions covering the sustainability and automation of supply chains. Engage in valuable discussion on meeting regulatory requirements and solving CMC challenges to improve process development.
Key Speakers include:
- Sarah Thomas, Senior Vice President, Quality, Regenixbio
- Guy McDonell, Senior Director, Global Technology & Engineering, Pfizer
- Kenneth Green, Senior Director, Vertex Pharmaceuticals
- Shilpi Rajoria, Director QC Analytical Testing, Bristol Myers Squibb
- Darrin Morrissey, Chief Executive Officer, National Institute for Bioprocessing Research & Training
Engage in solution-oriented dialogue with 15+ vendor companies over 2-days over multiple networking breaks with the opportunity to meet 1-2-1 and eliminate the challenges you face.
Do not miss this opportunity to engage with like-minded peers in the heart of Ireland to further your understanding of the cell and gene manufacturing. For more information, please contact h.liddiard@oxfordglobal.co.uk.
|
11
CGT Manufacturing 2023
Oxford Global’s Cell & Gene Therapy Manufacturing and Supply Chain Congress aim to address key bottlenecks within the supply and manufacture of cell and gene therapies globally. Taking place on the 10-11th May 2023, Ireland Dublin, the event aims to bring together key industry leaders in Ireland the hub of cell and gene therapy manufacturing investment.
Hear case studies on the cell and gene therapy landscape in Ireland, and the development of new manufacturing facilities. Presentations will showcase both viral and non-viral vector engineering and the acceleration of analytical tools and techniques to speed up process development, as well as streamlining CGT manufacture.
Connect with over 150 attendees and benefit from 20+ presentations and interactive sessions covering the sustainability and automation of supply chains. Engage in valuable discussion on meeting regulatory requirements and solving CMC challenges to improve process development.
Key Speakers include:
- Sarah Thomas, Senior Vice President, Quality, Regenixbio
- Guy McDonell, Senior Director, Global Technology & Engineering, Pfizer
- Kenneth Green, Senior Director, Vertex Pharmaceuticals
- Shilpi Rajoria, Director QC Analytical Testing, Bristol Myers Squibb
- Darrin Morrissey, Chief Executive Officer, National Institute for Bioprocessing Research & Training
Engage in solution-oriented dialogue with 15+ vendor companies over 2-days over multiple networking breaks with the opportunity to meet 1-2-1 and eliminate the challenges you face.
Do not miss this opportunity to engage with like-minded peers in the heart of Ireland to further your understanding of the cell and gene manufacturing. For more information, please contact h.liddiard@oxfordglobal.co.uk.
|
|
|
|
|
23
Single Cell Proteomics Online Symposium 2023
Oxford Global is proud to present its inaugural Single Cell Proteomics Symposium, online on 23rd May 2023- Tune in to join the conversation on advancements in single cell proteomics! Our key industry and academic leaders will be discussing topics, ranging from advancements in mass spectrometry and microfluidics, to case studies for novel disease applications such as oncology and immunology.
Discover the latest in overcoming sample preparation challenges, learn about the newest techniques for analysing data at the singe cell level, and get involved with our live panel discussions, focusing on the future of single cell proteomics from both technology and therapeutic viewpoints.
Key speakers include:
- David Goodlett, Professor And Director Of The UVIC Genome BC Proteomics Centre, University of Victoria
- Xiaoliang Sunney Xie, Professor, Peking University
- Manuel Fuentes Garcia, Senior Lecturer, University of Salamanca
- Kieran Campbell, Canada Research Chair In Machine Learning For Translational Biomedicine, University of Toronto
- Ahmet Coskun, Professor, Georgia Institute Of Technology
- Chris Rose, Director of Discovery Proteomics and Senior Scientist, Genentech
This 1-day symposium is full of engaging presentations, provoking insightful conversations with academics at the forefront of innovation in the single cell proteomics space. The morning session has a strong emphasis on analysis, techniques, and advanced technologies for single cell proteomics, whereas the afternoon session is more geared towards case studies and novel applications in the clinic.
So come and join over 150 delegates at our Next-Gen Omics series event!
|
24
Natural Killer Cell Online Symposium 2023
Oxford Global is proud to present the first Natural Killer Cell Symposium, a one-day virtual event set to take place on the 24th May 2023, EDT (UTC -4). This meeting will welcome over 150 attendees from across industry and academia, coming together on our intuitive virtual platform to discuss the latest developments in NK cell-based therapies for cancer.
Driven by current industry trends, presentations will cover topics ranging from allogeneic NK therapies, to the genetic modification of cells, to combination strategies with novel agents. We will also be exploring solid tumour targeting with NK cells, as well as examples of CAR-NK trials for haematological malignancies.
This BRAND-NEW event for 2023 will also feature live interactive sessions for you to get involved with – with Q&As throughout the day with our speakers and a panel discussion on:
- Optimal Cell Origins For Successful Application: iPSC, Cord, Or Peripheral Blood?
- Producing allogeneic NK therapies
- Combating persistence and cell exhaustion challenges
- Ensuring long-term efficacy with minimal repeat treatments
Explore the latest innovations in this fast-emerging area of immuno-oncology and learn more about how industry leaders are tackling industry-wide challenges, as well as the most recent research going into understanding the immune system to create more effective therapies.
Key speakers include:
- Jan Spanholtz, Chief Scientific Officer, Glycostem
- Marcela Guzman, Director, Immune Cell Therapy, Senti Biosciences
- Aviad Pato, Head Of Research, Natural Killer Cells, Gamida Cell
- Shawn Cogan, Senior CMC Project Manager, CMC Lead, Cell Therapies, Takeda
- Björn Önfelt, Professor of Applied Physics, KTH Royal Institute of Technology
With 10+ presentations, this exclusive one-day symposium offers unparalleled opportunity for new high-level scientific and business connections. Join our senior-level delegates and benefit from extensive opportunities for interactive discussion, alongside our jam-packed agenda of exciting presentations. For more information about the programme and registration, please contact us at d.dalby@oxfordglobal.co.uk.
|
25
Formulation & Delivery 2023
Oxford Global’s 9th Annual Formulation & Respiratory Drug Delivery Congress, 25 – 26 May 2023, London, UK will be attended by over 350 visionary leaders to network about the latest innovations in the field. With a revamped agenda, visionary leaders will be looking at novel approaches to both small & large molecule formulation development, exploring new drug delivery systems and stability & characterisation updates.
The event will be taking a deep dive into the following main themes:
- Day 1 Track 1: Small Molecule Drug Formulation
- Day 1 Track 2: Biologics Drug Delivery
- Day 1 Track 3: Bioanalysis: Stability, Characterisation, Developability
- Day 2 Track 1: Small Molecule Drug Delivery
- Day 2 Track 2: Multi Specific Antibodies, Cell Engagers & Other New Modalities
Key Speakers Include:
- Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG
- Werngard Czechtizky, Executive Director, Head of Medicinal Chemistry, AstraZeneca
- Ben Van Hove, Scientific Director, Janssen
- Norbert Lauber, Director, Autoinjectors & Pump Systems, Novartis
- Pawel Stasiak, Pharma Development Director, Zentiva
- Yogeshwar Bachhav, Associate Director, AiCuris Anti-infective Cures AG Germany
- Kathy Wang, Associate Director, AstraZeneca
Featuring a series of dedicated interactive sessions:
- Panel Discussion: Developability Assessment
- Panel Discussion: Small Molecule Formulation – Future Developments, Complexity & Novel Technologies
- Workshop: Oral Delivery Of Biologics
- Roundtable: Sustainability In Formulation Development
- Roundtable: Implementing Novel Bioanalytical Technique
- Roundtable: Advancing Biologics & New Modalities Drug Formulation
Co-located with the Inhalation & Respiratory Drug Delivery Congress. More information contact marketing@oxfordglobal.co.uk.
|
26
Formulation & Delivery 2023
Oxford Global’s 9th Annual Formulation & Respiratory Drug Delivery Congress, 25 – 26 May 2023, London, UK will be attended by over 350 visionary leaders to network about the latest innovations in the field. With a revamped agenda, visionary leaders will be looking at novel approaches to both small & large molecule formulation development, exploring new drug delivery systems and stability & characterisation updates.
The event will be taking a deep dive into the following main themes:
- Day 1 Track 1: Small Molecule Drug Formulation
- Day 1 Track 2: Biologics Drug Delivery
- Day 1 Track 3: Bioanalysis: Stability, Characterisation, Developability
- Day 2 Track 1: Small Molecule Drug Delivery
- Day 2 Track 2: Multi Specific Antibodies, Cell Engagers & Other New Modalities
Key Speakers Include:
- Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG
- Werngard Czechtizky, Executive Director, Head of Medicinal Chemistry, AstraZeneca
- Ben Van Hove, Scientific Director, Janssen
- Norbert Lauber, Director, Autoinjectors & Pump Systems, Novartis
- Pawel Stasiak, Pharma Development Director, Zentiva
- Yogeshwar Bachhav, Associate Director, AiCuris Anti-infective Cures AG Germany
- Kathy Wang, Associate Director, AstraZeneca
Featuring a series of dedicated interactive sessions:
- Panel Discussion: Developability Assessment
- Panel Discussion: Small Molecule Formulation – Future Developments, Complexity & Novel Technologies
- Workshop: Oral Delivery Of Biologics
- Roundtable: Sustainability In Formulation Development
- Roundtable: Implementing Novel Bioanalytical Technique
- Roundtable: Advancing Biologics & New Modalities Drug Formulation
Co-located with the Inhalation & Respiratory Drug Delivery Congress. More information contact marketing@oxfordglobal.co.uk.
|
|
|
|